Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced it will present new late-breaking data highlighting the clinical and economic ...

The FDA enlisted British drugmaker GSK to help it fast-track approval of leucovorin to treat an autism-related disorder.

More and more, as momentum builds for the soon-to-be-blockbuster Winrevair, Merck’s $11.5 billion buyout of Acceleron in 2021 is looking like a savvy move. | Paving the way for the label update were ...

A long-running confirmatory trial of two of Sarepta Therapeutics’ Duchenne muscular dystrophy drugs has missed its main goal.

While most over-the-counter pain relievers are not recommended for use during pregnancy, acetaminophen is backed by decades' ...

But according to wellness expert and Dietium.com founder Srasti, our collective reliance on this single number is “not just ...

Ad hoc announcement pursuant to Art. 53 LRComparable long-term effectiveness to standard of care corticosteroids over 5 years Normal growth ...

U.S. President Donald Trump's embrace of an old generic drug called leucovorin for use against a rare disorder that causes ...

Eli Lilly announced on Friday safety and efficacy results from two separate late-stage studies testing its approved drugs for ...

Supplements, especially in pill form, usually contain some type of bulking agent or filler to help achieve a uniform shape ...

A global analysis of 125 turmeric supplements across five major markets revealed widespread inconsistencies in labeling, ...